 |
Recombinant human histidyl-tRNA synthetase |
|---|---|
| Trade Name | |
| Orphan Indication | Limb-girdle muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-23 00:00:00 |
| Sponsor | aTyr Pharma;3545 John Hopkins Court, Suite 250;San Diego, California, 92121 |
